Classification of Proliferative Hepatocellular Lesions in Harlan Sprague–Dawley Rats Chronically Exposed to Dioxin-Like Compounds
暂无分享,去创建一个
Nigel J Walker | Abraham Nyska | N. Walker | A. Brix | A. Nyska | M. P. Jokinen | J. R. Hailey | James R Hailey | Donald M Sells | Amy E Brix | Michael P Jokinen | D. M. Sells
[1] Toxicology and carcinogenesis studies of 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4) in female Harlan Sprague-Dawley rats (gavage studies). , 2006, National Toxicology Program technical report series.
[2] Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (gavage studies). , 2006, National Toxicology Program technical report series.
[3] Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,3',4,4',5-pentachlorobiphenyl (PCB 118) (Cas No. 31508-00-6) in female Harlan Sprague-Dawley rats (gavage studies). , 2006, National Toxicology Program technical report series.
[4] A. Francavilla,et al. Hepatic regeneration , 1991, Digestive Diseases and Sciences.
[5] D. Sasse,et al. Metabolic zonation in thioacetamide-induced liver cirrhosis , 2004, Histochemistry.
[6] Randall G. Lee,et al. Tumors of the liver and intrahepatic bile ducts , 2003, American Journal of Gastroenterology.
[7] K. Imaida,et al. A Review of Nomenclature and Diagnostic Criteria for Proliferative Lesions in the Liver of Rats by a Working Group of the Japanese Society of Toxicologic Pathology , 2003 .
[8] G. Lucier,et al. Induction of hepatic 8-oxo-deoxyguanosine adducts by 2,3,7,8-tetrachlorodibenzo-p-dioxin in Sprague-Dawley rats is female-specific and estrogen-dependent. , 2001, Chemical research in toxicology.
[9] D. Harrison,et al. Apoptosis and carcinogenesis. , 1999, British journal of cancer.
[10] P. Hytiroglou,et al. Differential diagnosis of hepatocellular nodular lesions. , 1998, Seminars in diagnostic pathology.
[11] Y. Nakanuma,et al. Analytical histopathological diagnosis of small hepatocellular nodules in chronic liver disease. , 1998, Histology and histopathology.
[12] G. Lucier,et al. Differences in kinetics of induction and reversibility of TCDD-induced changes in cell proliferation and CYP1A1 expression in female Sprague-Dawley rat liver. , 1998, Carcinogenesis.
[13] Paulina Belle Nissenblatt. Liver , 1997, The Lancet.
[14] M. Bernasconi. Inhibition of apoptosis , 1997 .
[15] A. Buchmann,et al. Inhibition of apoptosis during 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated tumour promotion in rat liver. , 1995, Carcinogenesis.
[16] C. Sarraf,et al. Review : Apoptosis: regulation and relevance to toxicology , 1995 .
[17] S. Thung,et al. Macroregenerative nodules in a series of adult cirrhotic liver explants: Issues of classification and nomenclature , 1995, Hepatology.
[18] C. Sarraf,et al. Apoptosis: regulation and relevance to toxicology. , 1995, Human & experimental toxicology.
[19] T. Terada,et al. Frequent occurrence of hepatocellular carcinoma in cirrhotic livers after surgical resection of atypical adenomatous hyperplasia (borderline hepatocellular lesion): a follow-up study. , 1994, The American journal of gastroenterology.
[20] T. Terada,et al. Adenomatous hyperplasia of the liver as a precancerous lesion. , 2008, Liver.
[21] G. Clark,et al. Dose response for TCDD promotion of hepatocarcinogenesis in rats initiated with DEN: histologic, biochemical, and cell proliferation endpoints. , 1993, Environmental health perspectives.
[22] M. Kojiro,et al. Adenomatous hyperplasia in the vicinity of small hepatocellular carcinoma , 1992, Hepatology.
[23] J. Huff,et al. Chemicals associated with site-specific neoplasia in 1394 long-term carcinogenesis experiments in laboratory rodents. , 1991, Environmental health perspectives.
[24] R. Peters,et al. Tumors of the Liver and Intrahepatic Bile Ducts , 1990 .
[25] J. Mead,et al. Regulation of liver growth: protooncogenes and transforming growth factors. , 1989, Laboratory investigation; a journal of technical methods and pathology.
[26] F. Kondo,et al. Large regenerative nodules and dysplastic nodules in cirrhotic livers: A histopathologic study , 1988, Hepatology.
[27] D. V. van Thiel,et al. Rapid growth of an intact human liver transplanted into a recipient larger than the donor. , 1987, Gastroenterology.
[28] N. Nagasue,et al. Human liver regeneration after major hepatic resection. A study of normal liver and livers with chronic hepatitis and cirrhosis. , 1987, Annals of surgery.
[29] D. V. van Thiel,et al. Evidence that host size determines liver size: Studies in dogs receiving orthotopic liver transplants , 1987, Hepatology.
[30] E. Mcconnell,et al. National Toxicology Program Nomenclature for Hepatoproliferative Lesions of Rats , 1986, Toxicologic pathology.
[31] J. Huff,et al. Results from 86 two-year carcinogenicity studies conducted by the National Toxicology Program. , 1984, Journal of toxicology and environmental health.
[32] M. Greenblatt. Tumours of the liver. , 1982, IARC scientific publications.
[33] H. Pitot,et al. Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine. , 1980, Cancer research.
[34] Histologic typing of liver tumors of the rat. Institute of Laboratory Animal Resources, National Research Council, National Academy of Sciences, Washington, D.C. , 1980, Journal of the National Cancer Institute.
[35] C. Wade,et al. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. , 1978, Toxicology and applied pharmacology.
[36] L. Sobin,et al. The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. , 1978, Journal of clinical pathology.
[37] R. Squire,et al. Report of a workshop on classification of specific hepatocellular lesions in rats. , 1975, Cancer research.
[38] A. E. Rogers,et al. Animal model: fatty liver and cirrhosis in lipotrope-deficient male rats. , 1973, The American journal of pathology.